Alexandria Capital’s Allergan Inc AGN Stock Holding History

Alexandria Capital’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-200	Closed	-$43K	–	663
2014 Q4	$43K	Hold	200	–	–	0.02%	210
2014 Q3	$36K	Sell	200 -15	-7%	-$2.49K	0.02%	231
2014 Q2	$36K	Sell	215 -170	-44%	-$26.5K	0.02%	240
2014 Q1	$48K	Sell	385 -31	-7%	-$3.77K	0.02%	201
2013 Q4	$46K	Buy	416 +32	+8%	+$3.06K	0.02%	208
2013 Q3	$35K	Hold	384	–	–	0.02%	245
2013 Q2	$32K	Buy	+384	New	+$39.8K	0.02%	274

Other funds holding AGN

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return

ECM

Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return

HFS

HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Alexandria Capital's AGN Position: Q1 2015 in Review

Alexandria Capital sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 200 shares — an estimated $43K sold.

Alexandria Capital first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $48K in Q1 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

Alexandria Capital reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
Alexandria Capital sold 200 Allergan Inc shares in Q1 2015, an estimated $43K.
Alexandria Capital first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
Alexandria Capital's Allergan Inc position peaked at $48K in Q1 2014.
5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Alexandria Capital's 13F filing for Q1 2015, filed 1 May 2015.